Drug recall · December 18, 2013
Bumetanide Tablets USP 0.5 mg recall
Why: Failed Moisture Limit; Out of Specification (OOS) results were obtained for moisture content during stability testing at the 12 month time point, controlled room temperature conditions.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Bumetanide Tablets USP 0.5 mg. Rx Only, a) 100-count Bottle, b) 500-count Bottle, Sandoz Inc., Princeton, NJ 08540, NDC a) 0185-0128-01, b) 0185-0128-05
- Lots / codes
Lot #: a) CU6131, b) CW1161
- Quantity
- 11,496 bottles (100 count) and 62 bottles (500 count)
- Company
- Sandoz Inc, Wilson, NC
- Distribution
- Nationwide
- Initiated
- November 6, 2013 · Voluntary: Firm initiated
- Classified
- December 6, 2013
- Reported
- December 18, 2013
- Ended
- May 29, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bumetanide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.